The Union Budget 2026–27, presented by finance ministet Nirmala Sitharaman, laid out fiscal plans emphasizing infrastructure, growth, and human capital. Healthcare emerged as a priority, with higher allocations, major new initiatives, and structural policy reforms signalling a shift towards strengthening India’s health ecosystem. It allocates ₹1,05,530.42 crore to the healthcare sector, signaling a significant push for growth for various key measures.
According to the PIB press release in the Union Budget 2026–27, allocations to key flagship schemes have been significantly enhanced. The allocation for the Pradhan Mantri Ayushman Bharat Health Infrastructure Mission (PM-ABHIM) has been increased by 67.66%, rising to ₹4,770 crore in Budget Estimates (BE) 2026–27, to bolster public health infrastructure, disease surveillance, laboratories, and critical care facilities.
Further, the Pradhan Mantri Swasthya Suraksha Yojana (PMSSY) has been allocated ₹11,307 crore for FY 2026–27, marking an increase of ₹407 crore and a 3.73% rise over Revised Estimates (RE) 2025–26, to support the establishment of new AIIMS, strengthening of existing AIIMS, and upgradation of government medical colleges across the country.
Focused investments have also been made to reinforce public health systems, medical research, and regulatory capacity. The allocation for the National AIDS Control Organisation (NACO) has been raised to ₹3,477 crore in BE 2026–27, registering a 30.64% increase, with a major emphasis on strengthening blood transfusion services and national disease control programmes. Medical research funding has been enhanced, with the Department of Health Research receiving an allocation of over ₹4,821 crore, reflecting a 24% increase over the previous year. To advance pharmaceutical innovation, the government has announced ‘Bio Pharma Shakti’, a ₹10,000 crore national initiative aimed at promoting biologics, biosimilars, and research-driven pharmaceutical manufacturing.
As presented by the Economic Times, for the fiscal year 2026-27, the health sector outlay surpassed ₹1 lakh crore for the first time in India’s fiscal history. This increased investment covers both public health infrastructure and strategic initiatives aimed at pressing healthcare challenges such as non-communicable diseases (NCDs), mental health, and rising treatment costs, especially for cancer and rare diseases.
One of the most talked-about measures is the “Biopharma Shakti” programme, backed by a corpus of ₹10,000 crore over five years. Designed to propel India toward becoming a global biopharmaceutical manufacturing and innovation hub, it aims to strengthen advanced drug manufacturing (including biologics and biosimilars), support R&D and clinical development, and boost domestic capacity and global competitiveness. This initiative marks a shift from traditional pharmaceutical production to high-value science-driven healthcare products, closing the gap with global peers.
The budget proposes establishing five regional medical centres to improve accessibility, integrate diagnostics and care, and foster a continuum of services — especially outside metropolitan centers. Further ETHealthworld notes that the budget also proposes exemption of customs duty on selected cancer and rare disease medicines and aims to reduce treatment costs and enhance patient affordability. Plans further includes expanding emergency care capacity at district hospitals by up to 50%, improving trauma and acute care services across regions.
India’s healthcare manpower is set for expansion through establishing and upgrading institutions for Allied Health Professionals, covering disciplines such as radiology, optometry, rehabilitation, behavioural health, and more. Plans to add over 1 lakh trained allied health professionals and skills enhancement for care workers over the coming years. This focus is intended to strengthen frontline services, improve diagnostics, and reduce workforce shortages, especially in non-urban regions.
According to the New Indian Express, the budget discourse highlighted mental health as a critical area with expanded resource commitments — including proposals to strengthen key institutions and community-based care frameworks, underlining a broad understanding of healthcare beyond traditional disease care.
The Federal stated, although the budget reflects a strategic choice to invest in specialised and high-value segments of healthcare, including advanced pharmaceuticals, medical tourism, and traditional medicine, medical professionals argue that the continued neglect of primary healthcare and public health systems risks widening existing gaps in access and equity. As the budget moves towards implementation, this tension between specialized growth and universal healthcare needs is likely to remain at the centre of policy debate.
